These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12761499

  • 1. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
    Biggs PJ, Vogel H, Sage M, Martin LA, Donehower LA, Bradley A.
    Oncogene; 2003 May 22; 22(21):3288-96. PubMed ID: 12761499
    [Abstract] [Full Text] [Related]

  • 2. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
    French JE.
    IARC Sci Publ; 2004 May 22; (157):271-87. PubMed ID: 15055301
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE.
    Breast Cancer Res; 2006 May 22; 8(4):R38. PubMed ID: 16846527
    [Abstract] [Full Text] [Related]

  • 4. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A.
    Nature; 1992 Mar 19; 356(6366):215-21. PubMed ID: 1552940
    [Abstract] [Full Text] [Related]

  • 5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 6. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
    Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A.
    Nat Genet; 2001 Dec 01; 29(4):418-25. PubMed ID: 11694875
    [Abstract] [Full Text] [Related]

  • 7. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
    Maguire P, Holmberg K, Kost-Alimova M, Imreh S, Skoog L, Lindblom A.
    Int J Mol Med; 2005 Jul 01; 16(1):135-41. PubMed ID: 15942690
    [Abstract] [Full Text] [Related]

  • 8. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
    Boley SE, Anderson EE, French JE, Donehower LA, Walker DB, Recio L.
    Cancer Res; 2000 Jun 01; 60(11):2831-5. PubMed ID: 10850423
    [Abstract] [Full Text] [Related]

  • 9. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
    van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM.
    Breast Cancer Res; 2005 Jun 01; 7(6):R998-1004. PubMed ID: 16280054
    [Abstract] [Full Text] [Related]

  • 10. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
    Crabtree M, Sieber OM, Lipton L, Hodgson SV, Lamlum H, Thomas HJ, Neale K, Phillips RK, Heinimann K, Tomlinson IP.
    Oncogene; 2003 Jul 03; 22(27):4257-65. PubMed ID: 12833148
    [Abstract] [Full Text] [Related]

  • 11. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y, Zhang Z, Kastens E, Lubet RA, You M.
    Cancer Res; 2003 Aug 01; 63(15):4389-95. PubMed ID: 12907609
    [Abstract] [Full Text] [Related]

  • 12. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.
    Hum Mutat; 2005 Mar 01; 25(3):319. PubMed ID: 15712267
    [Abstract] [Full Text] [Related]

  • 13. Cooperative tumorigenic effects of germline mutations in Rb and p53.
    Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T.
    Nat Genet; 1994 Aug 01; 7(4):480-4. PubMed ID: 7951317
    [Abstract] [Full Text] [Related]

  • 14. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium.
    Clin Cancer Res; 2003 Oct 01; 9(12):4435-42. PubMed ID: 14555516
    [Abstract] [Full Text] [Related]

  • 15. Insights into aging obtained from p53 mutant mouse models.
    Dumble M, Gatza C, Tyner S, Venkatachalam S, Donehower LA.
    Ann N Y Acad Sci; 2004 Jun 01; 1019():171-7. PubMed ID: 15247009
    [Abstract] [Full Text] [Related]

  • 16. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P.
    Clin Cancer Res; 2006 Mar 15; 12(6):1693-700. PubMed ID: 16551851
    [Abstract] [Full Text] [Related]

  • 17. Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci.
    Cool M, Depault F, Jolicoeur P.
    Genes Chromosomes Cancer; 2006 Feb 15; 45(2):191-202. PubMed ID: 16258954
    [Abstract] [Full Text] [Related]

  • 18. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL, Su YR, Huang CS, Yu JC, Lo YL, Wu PE, Shen CY.
    Genes Chromosomes Cancer; 2004 Nov 15; 41(3):250-6. PubMed ID: 15334548
    [Abstract] [Full Text] [Related]

  • 19. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.
    Clin Cancer Res; 2007 Feb 01; 13(3):844-50. PubMed ID: 17289876
    [Abstract] [Full Text] [Related]

  • 20. Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice.
    Jenks PJ, Jeremy AH, Robinson PA, Walker MM, Crabtree JE.
    J Pathol; 2003 Dec 01; 201(4):596-602. PubMed ID: 14648663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.